| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/13/2010 | US20100120015 Method of collecting placental stem cells |
| 05/13/2010 | US20100119694 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 05/13/2010 | US20100119580 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 05/13/2010 | US20100119555 Methods and Compositions for the Treatment and Diagnosis of Cancer |
| 05/13/2010 | US20100119544 Vaccine |
| 05/13/2010 | US20100119523 Vascular endothelial cell growth factor antagonists |
| 05/13/2010 | US20100119522 Combination therapy for the treatment of ocular neovascular disorders |
| 05/13/2010 | US20100119512 Methods of diagnosing, treating, and preventing increased vascular permeability |
| 05/12/2010 | EP2183254A1 Inhibitors of protein tyrosine kinase activity |
| 05/12/2010 | EP1870409B1 Benzimidazole compounds |
| 05/12/2010 | EP1373262B1 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
| 05/12/2010 | EP1173169B1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 05/12/2010 | CN1835735B Drug delivery system for administering fine particle under tenon's capsule |
| 05/12/2010 | CN1671856B Novel physiologically active substances |
| 05/12/2010 | CN1642577B Preparation comprising buprenorphine |
| 05/12/2010 | CN1642552B 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 05/12/2010 | CN1636994B Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
| 05/12/2010 | CN101704785A Organic dicarboxylic acid and salts thereof and preparation method thereof |
| 05/12/2010 | CN101703687A Chinese medicinal decoction for treating glaucoma |
| 05/12/2010 | CN101703625A Oral Chinese medicinal composition for treating glaucoma |
| 05/12/2010 | CN101703559A Medicinal composition with function of relieving visual fatigue and preparation method thereof |
| 05/12/2010 | CN101703503A Application of organic dicarboxylic acid salts in preparing medicaments for preventing and treating cataract |
| 05/12/2010 | CN101703491A Vitamin a powder and preparation method thereof |
| 05/12/2010 | CN101019876B Compound roxithromycin dispersing tablet |
| 05/12/2010 | CN101015540B Refreshing eyedrop and its preparation |
| 05/12/2010 | CN101011489B Cordate houttuynia eye drops and its preparation method |
| 05/12/2010 | CN101011407B Amphotericin B liposome antigungal eye drops and its preparation method |
| 05/11/2010 | US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 05/11/2010 | US7714003 Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides |
| 05/11/2010 | CA2455134C Adjuvants for use in vaccines |
| 05/11/2010 | CA2428994C Improved ophthalmic and contact lens solutions containing forms of vitamin b |
| 05/11/2010 | CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 05/11/2010 | CA2184493C Methods and compositions useful for inhibition of angiogenesis |
| 05/06/2010 | WO2010050525A1 Compound having tafia inhibitory activity |
| 05/06/2010 | WO2010050167A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same |
| 05/06/2010 | WO2010048788A1 A ophthalmic flurbiprofen ester nano-emulsion in-situ gel formulation and the preparation method thereof |
| 05/06/2010 | WO2010009034A3 Method for treating atrophic age related macular degeneration |
| 05/06/2010 | WO2009133552A4 Methods of treating ophthalmic disorders |
| 05/06/2010 | WO2009013543A3 Targeted binging agents directed to kdr and uses thereof - 035 |
| 05/06/2010 | US20100113573 Modulation of hif1 beta expression |
| 05/06/2010 | US20100113535 Treatment of presbyopia with alpha- picolinic acid and its analogs |
| 05/06/2010 | US20100113516 Quinolynylmethylimidizoles as therapeutic agents |
| 05/06/2010 | US20100113501 Ophthalmic Composition Comprising Ascomycin |
| 05/06/2010 | US20100113481 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 05/06/2010 | US20100113456 Therapeutic agent for corneal disease |
| 05/06/2010 | US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1 |
| 05/06/2010 | US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| 05/06/2010 | US20100113361 Anti-ige vaccines |
| 05/06/2010 | US20100113338 Prophylactic or therapeutic agent for corneal/conjunctival disease |
| 05/06/2010 | US20100112106 Synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma |
| 05/06/2010 | US20100112016 Ophthalmic oil-in-water emulsions containing prostaglandins |
| 05/06/2010 | US20100111963 Method for treating age-related macular degeneration |
| 05/06/2010 | US20100111910 Treatment of excessive neovascularization |
| 05/06/2010 | US20100111898 Conjoint therapy for treating fibrotic diseases |
| 05/06/2010 | US20100111840 Stabilized therapeutic and imaging agents |
| 05/06/2010 | CA2741783A1 Compounds having tafia inhibitory activity |
| 05/05/2010 | EP2181110A2 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 05/05/2010 | EP2180898A2 The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases |
| 05/05/2010 | EP1461054B1 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/05/2010 | EP1326847B1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 05/05/2010 | EP1267894B1 Viscoelastics for use in middle ear surgery |
| 05/05/2010 | EP1166788B1 Remedies for joint diseases |
| 05/05/2010 | CN1964719B Use of loteprednol etabonate for the treatment of dry eye |
| 05/05/2010 | CN1947792B Method for preparing active protein composition type nano-selenium and its liquid phase storage tech. |
| 05/05/2010 | CN1863779B Novel indazole derivative |
| 05/05/2010 | CN1630526B Systems and methods for treating patients with processed lipoaspirate cells |
| 05/05/2010 | CN101700379A Traditional Chinese medicine preparation for treating central serous chorioretinopathy |
| 05/05/2010 | CN101700365A Functional beverage for improving vision |
| 05/05/2010 | CN101700362A Preparation method and quality detection method of traditional Chinese medicine preparation for recovering sight |
| 05/05/2010 | CN101700317A Preparation capable of improving fundus and retina microcirculation lesion and restoring ocular and retina microcirculation lesion and damage and method for preparing same |
| 05/05/2010 | CN101700305A Pill for clearing liver and improving vision |
| 05/05/2010 | CN101700285A Application of rumex japonicus in preparing medicines |
| 05/04/2010 | US7709669 Aspirin-triggered lipid mediators |
| 05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
| 05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 05/04/2010 | US7709500 Chemical compounds |
| 05/04/2010 | US7709479 Quinazoline derivatives and their use as pharmaceuticals |
| 05/04/2010 | US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 05/04/2010 | US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter |
| 05/04/2010 | US7709228 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
| 05/04/2010 | US7709020 Implantable device comprising phosphorus-containing macrolides |
| 05/04/2010 | CA2455566C (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 05/04/2010 | CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 05/04/2010 | CA2427608C Condensed pyradizindione derivatives as pde inhibitors |
| 05/04/2010 | CA2418395C Protein induced by homogeneous blood transfusion and dna encoding the same |
| 04/29/2010 | WO2010048365A2 Therapeutic peptide bioconjugates |
| 04/29/2010 | WO2010048332A2 Compounds for treating ophthalmic diseases and disorders |
| 04/29/2010 | WO2010048095A2 Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
| 04/29/2010 | WO2010047927A1 Ophthalmic compositions useful for improving visual acuity |
| 04/29/2010 | WO2010047803A2 A method for the treatment of proliferative disorders of the eye |
| 04/29/2010 | WO2010011609A3 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 04/29/2010 | WO2010005533A3 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| 04/29/2010 | US20100105896 Pharmaceutical compounds |
| 04/29/2010 | US20100105734 Treatment xerophthalmia with norketotifen |
| 04/29/2010 | US20100105712 Chemical compounds |
| 04/29/2010 | US20100105701 Gyrase inhibitors and uses thereof |
| 04/29/2010 | US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 04/29/2010 | US20100105650 Substituted isoquinoline and isoquinolinone derivatives |
| 04/29/2010 | US20100105643 Ophthalmic composition |